Search results for:
Entry into ICU market expands revenue potential
Following interest from Canadian Hospitals, Ondine prepares to enter the Intensive Care Unit (ICU) market Vancouver, British Columbia, Canada - April 4, 2024 Treatment of patients in ICUs would significantly expand Ondine’s potential market opportunity. Hundreds of thousands of patients are admitted to the ICU [...]
Steriwave study shows 77% drop in antibiotic use
Steriwave study shows 77% drop in antibiotic use Vancouver, British Columbia, Canada - March 21, 2024 Ondine Biomedical Inc. (LON:OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments to prevent and treat healthcare-associated infections (HAIs), announces that a UK-based study demonstrated a significant reduction [...]
Photodisinfection recommended as Standard of Care
Peer-reviewed publication involving 13,493 patients reports 66.5% decrease in spine surgery infection rate sustained over 8 years with the use of Steriwave® nasal photodisinfection Vancouver, British Columbia, Canada - November 16, 2023 Canadian life sciences company, Ondine Biomedical Inc. (OBI: LON), reports that an [...]
Steriwave named as SPIE Prism Awards finalist
Nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR Vancouver, British Columbia, Canada - November 10, 2023 Ondine Biomedical’s Steriwave nasal photodisinfection technology has been shortlisted in the biomedical category of the 2024 international society for optics and [...]
Steriwave use expanded following successful pilot
Alberta Health Services has expanded its use of Steriwave nasal photodisinfection to reduce the incidence of surgical site infections (SSIs) in orthopedic surgery following a successful pilot at the Mazankowski Alberta Heart Institute Vancouver, British Columbia, Canada - October 31, 2023 SSIs, the most [...]
66.5% reduction in spine surgery infection rate
Pre-surgical Steriwave® nasal photodisinfection protocol contributed to 66.5% reduction in spine surgery infection rates and $2.5 million annual savings in Vancouver General Hospital Vancouver, British Columbia, Canada - October 23, 2023 Canadian life sciences company, Ondine Biomedical Inc. (OBI: LON), reports new independent research [...]
Steriwave shown to reduce resistant bacteria by >99.9%
Steriwave shown to reduce resistant bacteria by >99.9% Read article in The Microbiologist Vancouver, British Columbia, Canada - October 18, 2023 New research presented by Ondine shows that Steriwave photodisinfection reduces antibiotic-resistant bacteria by more than 99.9% without generating resistance. The research suggests [...]
Steriwave available coast-to-coast across Canada
Nova Scotia’s largest hospital is the latest to implement Steriwave nasal photodisinfection for use prior to orthopedic surgery Vancouver, British Columbia, Canada - October 13, 2023 Canadian life sciences company Ondine Biomedical’s (LON: OBI) Steriwave® nasal photodisinfection for the prevention of healthcare-associated infections (HAIs) [...]
Montreal Heart Institute pilots Steriwave
Second Quebec-based hospital pilots nasal photodisinfection to reduce antibiotic resistance Vancouver, British Columbia, Canada - September 21, 2023 The world-renowned Montreal Heart Institute and Hôpital Fleurimont, University of Sherbrooke (CHUS) in Sherbrooke, Quebec are piloting nasal photodisinfection to prevent post-operative infections in an era [...]
Steriwave proven highly effective against XDR bacteria
Ondine Biomedical presents research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023, Geneva Vancouver, British Columbia, Canada - September 14, 2023 Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has presented new research at the 2023 International Consortium on Prevention [...]
For Media Information
Simon Vane Percy
Amanda Bernard
